Dogwood Therapeutics, Inc. (DWTX) Presentations https://ir.dwtx.com/events-presentations/presentations/rss Please specify a description for this RSS Feed en-us https://d1io3yog0oux5.cloudfront.net/_9f55823e9477de6aca19e5bcf0d048d4/virios/files/theme/images/DogwoodLogo.png Dogwood Therapeutics, Inc. Logo Equisolve Investor Relations Suite <![CDATA[Corporate Presentation]]> https://d1io3yog0oux5.cloudfront.net/_949f9378eeadddccecf946c5dfe9f242/dwtx/db/858/7612/pdf/Dogwood+Non-Confidential+Corporate+Update+May+2026.pdf Tue, 12 May 26 00:00:00 -0400 https://d1io3yog0oux5.cloudfront.net/_949f9378eeadddccecf946c5dfe9f242/dwtx/db/858/7612/pdf/Dogwood+Non-Confidential+Corporate+Update+May+2026.pdf <![CDATA[Corporate Presentation]]> https://d1io3yog0oux5.cloudfront.net/_949f9378eeadddccecf946c5dfe9f242/dwtx/db/858/7593/pdf/Investor+Meeting+Presentation+Sept+29+2025.pdf Mon, 29 Sep 25 00:00:00 -0400 https://d1io3yog0oux5.cloudfront.net/_949f9378eeadddccecf946c5dfe9f242/dwtx/db/858/7593/pdf/Investor+Meeting+Presentation+Sept+29+2025.pdf <![CDATA[FORTRESS Study Summary]]> https://d1io3yog0oux5.cloudfront.net/_949f9378eeadddccecf946c5dfe9f242/dwtx/db/858/7518/pdf/Investor+Update+on+FORTRESS-Sept+19-2022-Final+v4.pdf Mon, 19 Sep 22 00:00:00 -0400 https://d1io3yog0oux5.cloudfront.net/_949f9378eeadddccecf946c5dfe9f242/dwtx/db/858/7518/pdf/Investor+Update+on+FORTRESS-Sept+19-2022-Final+v4.pdf <![CDATA[International Association for the Study of Pain (IASP) World Congress 2021 Poster Presentation - William Pridgen, MD; Carol Duffy, PhD; Judy F. Gendreau, MD; R. Michael Gendreau, MD, PhD – The Safety of IMC‑1 in Patients With Fibromyalgia: Phase 2a Study Results]]> https://d1io3yog0oux5.cloudfront.net/_949f9378eeadddccecf946c5dfe9f242/dwtx/db/858/7490/pdf/IASP+Poster+Presentation_Prigden_Duffy_JF+Gendreau_RMGendreau+6_9_21.pdf Sun, 17 May 26 04:11:06 -0400 https://d1io3yog0oux5.cloudfront.net/_949f9378eeadddccecf946c5dfe9f242/dwtx/db/858/7490/pdf/IASP+Poster+Presentation_Prigden_Duffy_JF+Gendreau_RMGendreau+6_9_21.pdf <![CDATA[EULAR European Congress of Rheumatology 2021 Poster Presentation - William Pridgen, MD; Carol Duffy, PhD; Judy F. Gendreau, MD; R. Michael Gendreau, MD, PhD – IMC‑1, a Fixed Dose Combination of Famciclovir and Celecoxib, Improves Common Symptoms Associated With Fibromyalgia in Addition to Pain: Post Hoc Analysis of a Phase 2a Trial]]> https://d1io3yog0oux5.cloudfront.net/_949f9378eeadddccecf946c5dfe9f242/dwtx/db/858/7489/pdf/EULAR+Poster+Presentation_Pridgen_Duffy_JFGendreau_RMGendreau+6_2_21.pdf Sun, 17 May 26 04:11:06 -0400 https://d1io3yog0oux5.cloudfront.net/_949f9378eeadddccecf946c5dfe9f242/dwtx/db/858/7489/pdf/EULAR+Poster+Presentation_Pridgen_Duffy_JFGendreau_RMGendreau+6_2_21.pdf <![CDATA[Digestive Disease Week® (DDW) 2021 Presentation – Carol Duffy, PhD; William Pridgen, MD – Active Herpes Simplex Virus Type 1 Infection of the Gastric Mucosa is Associated with Functional Gastrointestinal Disorders: A Pilot Case-Control Study]]> https://d1io3yog0oux5.cloudfront.net/_949f9378eeadddccecf946c5dfe9f242/dwtx/db/858/7487/pdf/DDW+Presentation_Duffy_Pridgen+5_23_21.pdf Sun, 17 May 26 04:11:06 -0400 https://d1io3yog0oux5.cloudfront.net/_949f9378eeadddccecf946c5dfe9f242/dwtx/db/858/7487/pdf/DDW+Presentation_Duffy_Pridgen+5_23_21.pdf <![CDATA[Journal of Pain Research – William Pridgen, MD; Carol Duffy, PhD; Judy F. Gendreau, MD; R. Michael Gendreau, MD, PhD – A Famciclovir + Celecoxib Combination Treatment is Safe and Efficacious in the Treatment of Fibromyalgia]]> https://www.dovepress.com/a-famciclovir--celecoxib-combination-treatment-is-safe-and-efficacious-peer-reviewed-fulltext-article-JPR Sun, 17 May 26 04:11:06 -0400 https://www.dovepress.com/a-famciclovir--celecoxib-combination-treatment-is-safe-and-efficacious-peer-reviewed-fulltext-article-JPR